PATENT CLAIM ANALYSIS

Application Number: 15874140
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["546", "083000"]

Abstract:
The present invention provides tricyclic fused thiophene derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.

Claim (Index 73):
The method of  claim 70 , wherein the disease is allograft rejection.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.42857
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14872948', '14873078', '14068796', '14697236', '14289121']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7307127006644194
- 35 USC 102 Novelty (BERT): 0.543833857453735
- Combined Prediction Score: 0.712024816343351
- Mean Citation Score: 370.93873
- Max Citation Score: 398.03116
- Similarity Product: 220.8926349022937

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test